Ryan Scott, DPM
Foot & Ankle Surgery · Phoenix, AZNPI 1053554600
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (45.4%), royalties or licence payments and travel and lodging — rather than concentrated in one kind of arrangement. 32 manufacturers reported payments, led by Stryker at 54.9% of the total. 2025 is the largest year on record at $268,180, 3.1 times the $87,138 reported in 2019. Among foot & ankle surgery clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 892 payments — averaging $1264.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$619K
- International Life Sciences$294K
- Medline Industries LP$128K
- Anika Therapeutics, Inc.$56K
- Parcus Medical, LLC$11K
- Amniox Medical, Inc.$7K
- plus $13K from 26 others
Across 10 payments — averaging $804.63 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biotissue Holdings Inc.$6K
- Stryker$2K
What the payments were for
- Royalty or licence$482,06843%
- Consulting fees$512,34345%
- Speaking & faculty fees$32,3163%
- Travel & lodging$77,9007%
- Food & beverage$22,8952%
- Gifts$460%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker(2 entities) | 533 | $619,279 |
| International Life Sciences | 27 | $293,906 |
| Medline Industries LP | 61 | $128,214 |
| Anika Therapeutics, Inc. | 39 | $55,576 |
| Parcus Medical, LLC | 4 | $10,967 |
| Amniox Medical, Inc. | 5 | $6,660 |
| Trice Medical, Inc. | 10 | $5,181 |
| Paragon 28, Inc. | 6 | $1,135 |
| Avanos Medical | 9 | $1,104 |
| Medshape, Inc. | 4 | $1,049 |
| Orthofix Medical, Inc. | 108 | $990 |
| Bioventus LLC | 45 | $707 |
| Flower Orthopedics Coporation | 5 | $482 |
| Kuros Biosciences USA, Inc | 3 | $415 |
| Biotissue Holdings Inc. | 3 | $300 |
| Smith+Nephew | 7 | $240 |
| Linvatec Corporation | 4 | $205 |
| Novastep Inc. | 1 | $191 |
| Biogennix, LLC | 1 | $158 |
| Medartis Inc. | 1 | $151 |
| Goode Surgical Inc | 1 | $121 |
| X-spine Systems, Inc. | 1 | $114 |
| Sanara Medtech Inc. | 1 | $77 |
| Restor3d, Inc. | 1 | $77 |
| Celularity Inc. | 1 | $74 |
| Amgen | 4 | $58 |
| Johnson & Johnson | 2 | $33 |
| Ossio Inc | 1 | $32 |
| Carestream Health, Inc. | 1 | $22 |
| Acell, Inc. | 1 | $16 |
| Bayer | 1 | $15 |
| AbbVie | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FLEXBAND$401,175
- MEDLINE UNITE$169,642
- PROstep$142,350
- ORTHOLOC 2 LAPIFUSE$128,128
- INFINITY$99,638
- PROPHECY$65,661
- T2$60,492
- SALVATION$51,083
- INBONE$49,277
- ORTHOLOC 3DI$36,580
- HOFFMANN$33,339
- GRAVITY SYNCHFIX$30,150
- Dermatology and Wound Care$27,252
- Arthrosurface Hammertoes$25,074
- mild Device Kit$22,797
- MEDLINE INDUSTRIES, INC.$21,600
- TACTOSET$20,095
- FIXOS$16,064
- MEDLINE$14,690
- MJFS4536$14,162
How this compares
$1,127,567 in reported general payments places this provider in the 95th percentile of 291 foot & ankle surgery providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 52 | $1,305 |
| Gabapentin | 55 | $872 |
| Ondansetron Hcl | 114 | $815 |
| Meloxicam | 100 | $629 |
| Methylprednisolone | 81 | $615 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 75 | $525 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 47 | $446 |
| Diclofenac Sodium | 13 | $353 |
| Ibuprofen | 11 | $248 |
| Pregabalin | 22 | $224 |
| Tramadol Hcl | 22 | $87 |
| Prednisone | 11 | $21 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Phoenix
- Jeffrey HolmesPhoenix$509K
- Melissa GalliPhoenix$324K
- Zachary FlynnPhoenix$239K
- Kyle VaughnPhoenix$110K
- David JaffePhoenix$75K
- Jason KaycePhoenix$57K
- Devin BlandPhoenix$49K
- Braden BoyerPhoenix$32K
- Martin WeismanPhoenix$31K
- Eugene Dela CruzPhoenix$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.